- Home
- FCFS vs ALKS Comparison
FCFS vs ALKS Comparison
Compare FCFS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCFS
- ALKS
- Stock Information
- Founded
- FCFS 1988
- ALKS 1987
- Country
- FCFS United States
- ALKS Ireland
- Employees
- FCFS N/A
- ALKS N/A
- Industry
- FCFS Other Specialty Stores
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FCFS Consumer Discretionary
- ALKS Health Care
- Exchange
- FCFS Nasdaq
- ALKS Nasdaq
- Market Cap
- FCFS 5.2B
- ALKS 5.7B
- IPO Year
- FCFS 1991
- ALKS 1991
- Fundamental
- Price
- FCFS $114.59
- ALKS $35.32
- Analyst Decision
- FCFS Strong Buy
- ALKS Buy
- Analyst Count
- FCFS 4
- ALKS 12
- Target Price
- FCFS $135.67
- ALKS $37.25
- AVG Volume (30 Days)
- FCFS 236.2K
- ALKS 1.9M
- Earning Date
- FCFS 01-30-2025
- ALKS 02-12-2025
- Dividend Yield
- FCFS 1.33%
- ALKS N/A
- EPS Growth
- FCFS 19.38
- ALKS 3.47
- EPS
- FCFS 5.73
- ALKS 2.17
- Revenue
- FCFS $3,388,514,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- FCFS $2.52
- ALKS N/A
- Revenue Next Year
- FCFS $5.44
- ALKS $4.67
- P/E Ratio
- FCFS $20.07
- ALKS $16.28
- Revenue Growth
- FCFS 7.51
- ALKS N/A
- 52 Week Low
- FCFS $100.24
- ALKS $22.90
- 52 Week High
- FCFS $133.64
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- FCFS 55.72
- ALKS 71.72
- Support Level
- FCFS $113.56
- ALKS $31.01
- Resistance Level
- FCFS $118.87
- ALKS $36.45
- Average True Range (ATR)
- FCFS 2.50
- ALKS 1.05
- MACD
- FCFS -0.09
- ALKS 0.32
- Stochastic Oscillator
- FCFS 64.63
- ALKS 81.57
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.